Skip to main content

Part of the book series: Infectious Disease ((ID))

  • 214 Accesses

Abstract

Infections of the central nervous system (CNS) continue to be a major health social and economic toll on society due to the significant morbidity and mortality associated with these infections. Proper recognition and early treatment can have a significant impact on outcome of most of these infections. This chapter presents a syndrome-oriented clinical approach to a patient with CNS infection with an emphasis on antimicrobial therapy (see Table 1). Specifically, we focus on acute and chronic meningitis, acute and chronic encephalitis, and space-occupying lesion syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Berger JR. Benign aseptic (Mollaret’s) meningitis after genital herpes. Lancet 1991; 337: 1360–1361.

    Article  PubMed  CAS  Google Scholar 

  2. Fiore AE, Moroney JF, Farley MM, et al. Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance. Clin Infect Dis 2000; 30: 71–77.

    Article  PubMed  CAS  Google Scholar 

  3. Balkundi DR, Murray DL, Patterson MJ, Gera R, Scott-Emuakpor A, Kulkarni R. Penicillin-resistant Streptococcus mitis as a cause of septicemia with meningitis in febrile neutropenic children. J Pediatr Hematol Oncol 1997; 19: 82–85.

    Article  PubMed  CAS  Google Scholar 

  4. Coyle PK. Glucocorticoids in central nervous system bacterial infection. Arch Neurol 1999; 56: 796–801.

    Article  PubMed  CAS  Google Scholar 

  5. Reik L. Lyme Disease. Philadelphia: Lippincott-Raven, 1997.

    Google Scholar 

  6. Karstaedt AS, Valtchanova S, Barriere R, Crewe-Brown HH. Tuberculous meningitis in South African urban adults. QJM 1998; 91: 743–747.

    Article  PubMed  CAS  Google Scholar 

  7. Flood JM, Weinstock HS, Guroy ME, Bayne L, Simon RP, Bolan G. Neurosyphilis during the AIDS epidemic, San Francisco, 1985–1992. J Infect Dis 1998; 177: 931–940.

    Article  PubMed  CAS  Google Scholar 

  8. de Souza MC, Nitrini R. Effects of human immunodeficiency virus infection on the manifestations of neurosyphilis. Neurology 1997; 49: 893–894.

    Article  PubMed  Google Scholar 

  9. Bogaerts J, Rouvroy D, Taelman H, et al. AIDS-associated cryptococcal meningitis in Rwanda (1983–1992): epidemiologic and diagnostic features. J Infect 1999; 39: 32–37.

    Article  PubMed  CAS  Google Scholar 

  10. Donald PR, Schoeman JF, Cotton MF, van Zyl LE. Cerebrospinal fluid investigations in tuberculous meningitis. Ann Trop Paediatr 1991; 11: 241–246.

    PubMed  CAS  Google Scholar 

  11. Teoh R, O’Mahony G, Yeung VT. Polymorphonuclear pleocytosis in the cerebrospinal fluid during chemotherapy for tuberculous meningitis. J Neurol 1986; 233: 237–241.

    Article  PubMed  CAS  Google Scholar 

  12. Roos KL. Neurosyphilis. Semin Neurol 1992; 12: 209–212.

    Article  PubMed  CAS  Google Scholar 

  13. Lukehart SA, Hook EWd, Baker-Zander SA, Collier AC, Critchlow CW, Handsfield HH. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med 1988; 109: 855–862.

    Article  PubMed  CAS  Google Scholar 

  14. Brown SL, Hansen SL, Langone JJ. Role of serology in the diagnosis of Lyme disease [see comments]. JAMA 1999; 282: 62–66.

    Article  PubMed  CAS  Google Scholar 

  15. Folgueira L, Delgado R, Palenque E, Noriega AR. Polymerase chain reaction for rapid diagnosis of tuberculous meningitis in AIDS patients. Neurology 1994; 44: 1336–1338.

    Article  PubMed  CAS  Google Scholar 

  16. Macher A, Goosby E, Beller M. PCR and the misdiagnosis of active tuberculosis. N Engl J Med 1995; 332: 128–129.

    Article  PubMed  CAS  Google Scholar 

  17. Saag MS, Cloud GA, Graybill JR, et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis 1999; 28: 291–296.

    Article  PubMed  CAS  Google Scholar 

  18. Lu CH, Chang WN, Chang HW, Chuang YC. The prognostic factors of cryptococcal meningitis in HIV-negative patients. J Hosp Infect 1999; 42: 313–320.

    Article  PubMed  CAS  Google Scholar 

  19. Robinson PA, Bauer M, Leal MA, et al. Early mycological treatment failure in AIDS-associated cryptococcal meningitis. Clin Infect Dis 1999; 28: 82–92.

    Article  PubMed  CAS  Google Scholar 

  20. Roos KL. Pearls and pitfalls in the diagnosis and management of central nervous system infectious diseases. Semin Neurol 1998; 18: 185–196.

    Article  PubMed  CAS  Google Scholar 

  21. American Academy of Pediatrics Committee on Infectious Diseases. Chemotherapy for tuberculosis in infants and children. Pediatrics 1992; 89: 161–165.

    Google Scholar 

  22. Kaojarern S, Supmonchai K, Phuapradit P, Mokkhavesa C, Krittiyanunt S. Effect of steroids on cerebrospinal fluid penetration of antituberculous drugs in tuberculous meningitis. Clin Pharmacol Ther 1991; 49: 6–12.

    Article  PubMed  CAS  Google Scholar 

  23. CDC. Sexually transmitted diseases treatment guidelines. MMWR 1989; 38 (Suppl 8): 9.

    Google Scholar 

  24. Emskotter T, Jenzevski H, Pulz M, Spehn J. Neurosyphilis in HIV infection-persistence after high-dose penicillin therapy. J Neuroimmunol 1988; 20: 153–155.

    Article  PubMed  CAS  Google Scholar 

  25. Marra CM, Longstreth WT Jr, Maxwell CL, Lukehart SA. Resolution of serum and cerebrospinal fluid abnormalities after treatment of neurosyphilis. Influence of concomitant human immunodeficiency virus infection. Sex Transm Dis 1996; 23: 184–189.

    Article  PubMed  CAS  Google Scholar 

  26. Pfister HW, Preac-Mursic V, Wilske B, Schielke E, Sorgel F, Einhaupl KM. Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis. J Infect Dis 1991; 163: 311–318.

    Article  PubMed  CAS  Google Scholar 

  27. Logigian EL, Kaplan RF, Steere AC. Successful treatment of Lyme encephalopathy with intravenous ceftriaxone. J Infect Dis 1999; 180: 377–383.

    Article  PubMed  CAS  Google Scholar 

  28. Pfister HW, Preac-Mursic V, Wilske B, Einhaupl KM. Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis. A prospective randomized study. Arch Neurol 1989; 46: 1190–1194.

    Article  PubMed  CAS  Google Scholar 

  29. Kohlhepp W, Oschmann P, Mertens HG. Treatment of Lyme borreliosis. Randomized comparison of doxycycline and penicillin G. J Neurol 1989; 236: 464–469.

    Article  PubMed  CAS  Google Scholar 

  30. Dotevall L, Hagberg L. Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis. Clin Infect Dis 1999; 28: 569–574.

    Article  PubMed  CAS  Google Scholar 

  31. Loewen PS, Marra CA, Marra F. Systematic review of the treatment of early Lyme disease. Drugs 1999; 57: 157–173.

    Article  PubMed  CAS  Google Scholar 

  32. Miller JL. Lyme disease vaccine cleared for marketing [news]. Am J Health Syst Pharm 1999; 56: 206.

    PubMed  CAS  Google Scholar 

  33. Hemachudha T, Phuapradit P. Rabies. Curr Opin Neurol 1997; 10: 260–267.

    Article  PubMed  CAS  Google Scholar 

  34. Tebas P, Nease RF, Storch GA. Use of the polymerase chain reaction in the diagnosis of herpes simplex encephalitis: a decision analysis model. Am J Med 1998; 105: 287–295.

    Article  PubMed  CAS  Google Scholar 

  35. Cinque P, Vago L, Marenzi R, et al. Herpes simplex virus infections of the central nervous system in human immunodeficiency virus-infected patients: clinical management by polymerase chain reaction assay of cerebrospinal fluid. Clin Infect Dis 1998; 27: 303–309.

    Article  PubMed  CAS  Google Scholar 

  36. Roos KL. Encephalitis. Neurol Clin 1999; 17: 813–833.

    Article  PubMed  CAS  Google Scholar 

  37. Burke DG, Leonard DG, Imperiale TF, et al. The utility of clinical and radiographic features in the diagnosis of cytomegalovirus central nervous system disease in AIDS patients. Mol Diagn 1999; 4: 37–43.

    Article  PubMed  CAS  Google Scholar 

  38. Keating MR. Antiviral agents for non-human immunodeficiency virus infections. Mayo Clin Proc 1999; 74: 1266–1283.

    Article  PubMed  CAS  Google Scholar 

  39. Hanlon CA, Smith JS, Anderson GR. Recommendations of a national working group on prevention and control of rabies in the United States. Article H: Laboratory diagnosis of rabies. The National Working Group on Rabies Prevention and Control. J Am Vet Med Assoc 1999; 215: 1444–1446.

    Google Scholar 

  40. Rose VL. CDC issues revised guidelines for the prevention of human rabies. Am Fam Phys 1999; 59: 2007–2008, 2013–2014.

    Google Scholar 

  41. Lahat E, Barr J, Barkai G, Paret G, Brand N, Barzilai A. Long term neurological outcome of herpes encephalitis. Arch Dis Child 1999; 80: 69–71.

    Article  PubMed  CAS  Google Scholar 

  42. Ito Y, Kimura H, Yabuta Y, et al. Exacerbation of herpes simplex encephalitis after successful treatment with acyclovir. Clin Infect Dis 2000; 30: 185–187.

    Article  PubMed  CAS  Google Scholar 

  43. Berger JR, Pall L, Lanska D, Whiteman M. Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 1998; 4: 59–68.

    Article  PubMed  CAS  Google Scholar 

  44. Bouwman FH, Skolasky RL, Hes D, et al. Variable progression of HIV-associated dementia. Neurology 1998; 50: 1814–1820.

    Article  PubMed  CAS  Google Scholar 

  45. Berger JR, Levy RM, Flomenhoft D, Dobbs M. Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol 1998; 44: 341–349.

    Article  PubMed  CAS  Google Scholar 

  46. Anlar B, Yalaz K, Kose G, Saygi S. Beta-interferon plus inosiplex in the treatment of subacute sclerosing panencephalitis. J Child Neurol 1998; 13: 557–559.

    Article  PubMed  CAS  Google Scholar 

  47. Nath A, Hobson DE, Russell A. Movement disorders with cerebral toxoplasmosis and AIDS. Mov Disord 1993; 8: 107–112.

    Article  PubMed  CAS  Google Scholar 

  48. Marra CM, Krone MR, Koutsky LA, Holmes KK. Diagnostic accuracy of HIV-associated central nervous system toxoplasmosis. Int J STD AIDS 1998; 9: 761–764.

    Article  PubMed  CAS  Google Scholar 

  49. Cingolani A, De Luca A, Ammassari A, et al. PCR detection of Toxoplasma gondii DNA in CSF for the differential diagnosis of AIDS-related focal brain lesions. J Med Microbiol 1996; 45: 472–476.

    Article  PubMed  CAS  Google Scholar 

  50. Brightbill TC, Post MJ, Hensley GT, Ruiz A. MR of Toxoplasma encephalitis: signal characteristics on T2-weighted images and pathologic correlation. J Comput Assist Tomogr 1996; 20: 417–422.

    Article  PubMed  CAS  Google Scholar 

  51. Fung HB, Kirschenbaum HL. Treatment regimens for patients with toxoplasmic encephalitis. Clin Ther 1996; 18:1037–1056; discussion 1036.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Nath, A., Berger, J. (2001). Infections of the Central Nervous System. In: Mainous, A.G., Pomeroy, C. (eds) Management of Antimicrobials in Infectious Diseases. Infectious Disease. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-036-0_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-036-0_14

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-5708-8

  • Online ISBN: 978-1-59259-036-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics